Related references
Note: Only part of the references are listed.Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy
Raquel A. Nunes et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Biospecimen Reporting for Improved Study Quality
Helen M. Moore et al.
BIOPRESERVATION AND BIOBANKING (2011)
Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
Gerhard F. Huber et al.
BMC CANCER (2011)
Biomarker studies: a call for a comprehensive biomarker study registry
Fabrice Andre et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
New Prognostic Markers for Outcome of Acute Pancreatitis Overview of Reporting in 184 Studies
Dimitrios E. Sigounas et al.
PANCREAS (2011)
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
S. Mallett et al.
BRITISH JOURNAL OF CANCER (2010)
Prognostic Criteria for Squamous Cell Cancer of the Skin
Vanessa Jensen et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Randomized Clinical Trials With Biomarkers: Design Issues
Boris Freidlin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Increased shedding of HU177 correlates with worse prognosis in primary melanoma
Heather K. Hamilton et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease
Harry Hemingway et al.
PLOS MEDICINE (2010)
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
Robin L. Jones et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial
George Pentheroudakis et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond
R. D. Riley et al.
BRITISH JOURNAL OF CANCER (2009)
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
D. Loussouarn et al.
BRITISH JOURNAL OF CANCER (2009)
Glucose as a Prognostic Factor in Ovarian Carcinoma
Donald M. Lamkin et al.
CANCER (2009)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Diagnostic and Prognostic Impact of Osteopontin Expression in Endometrial Cancer
HanByoul Cho et al.
CANCER INVESTIGATION (2009)
p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803
Monica M. Bertagnolli et al.
CLINICAL CANCER RESEARCH (2009)
Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical Trial
Ji-Yeob Choi et al.
CLINICAL CANCER RESEARCH (2009)
Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis
Penelope A. Bradbury et al.
CLINICAL CANCER RESEARCH (2009)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
Amanda Blackford et al.
CLINICAL CANCER RESEARCH (2009)
Cutpoints in Clinical Chemistry: Time for Fundamental Reassessment
Andrew J. Vickers et al.
CLINICAL CHEMISTRY (2009)
CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma
Gertraud Stocker et al.
EUROPEAN JOURNAL OF CANCER (2009)
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients
Giovanni Lughezzani et al.
EUROPEAN JOURNAL OF CANCER (2009)
Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score
Ioanna Tzoulaki et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
A systematic review of trends in the methodological quality of randomized controlled trials in various research fields
Matthew E. Falagas et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial
Michael S. Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients
Brandon L. Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
MALDI-Ion Mobility Separation-Mass Spectrometry Imaging of Glucose-Regulated Protein 78 kDa (Grp78) in Human Formalin-Fixed, Paraffin-Embedded Pancreatic Adenocarcinoma Tissue Sections
Marie-Claude Djidja et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
Bonnie E. Gould Rothberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Estrogen Receptor-α Phosphorylation at Serine-118 and Tamoxifen Response in Breast Cancer
Marleen Kok et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Weighted analyses for cohort sampling designs
Robert J. Gray
LIFETIME DATA ANALYSIS (2009)
Limited Value of CA 19-9 in Predicting Early Treatment Failure in Patients with Advanced Pancreatic Cancer
Laurenz Vormittag et al.
ONCOLOGY (2009)
Imputing missing covariate values for the Cox model
Ian R. White et al.
STATISTICS IN MEDICINE (2009)
Blood Markers for the Prognosis of Ischemic Stroke A Systematic Review
William Whiteley et al.
STROKE (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Prognosis and prognostic research: validating a prognostic model
Douglas G. Altman et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients
Yi Yan et al.
BREAST CANCER RESEARCH (2009)
Use of multiple imputation in the epidemiologic literature
Mark A. Klebanoff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Independent Predictors from Stepwise Logistic Regression May Be Nothing More. than Publishable P Values
Nathan L. Pace
ANESTHESIA AND ANALGESIA (2008)
Measuring follow-up completeness
YingXing Wu et al.
ANNALS OF THORACIC SURGERY (2008)
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
P. de Graeff et al.
BRITISH JOURNAL OF CANCER (2008)
Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma
Wei-Chih Liao et al.
CLINICAL CANCER RESEARCH (2008)
Validation of Biomarker-Based Risk Prediction Models
Jeremy M. G. Taylor et al.
CLINICAL CANCER RESEARCH (2008)
Reporting bias in diagnostic and prognostic studies: Time for action
Nader Rifai et al.
CLINICAL CHEMISTRY (2008)
S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients
B. Gazic et al.
CYTOPATHOLOGY (2008)
The search for truth must go beyond statistics
Walter C. Willett
EPIDEMIOLOGY (2008)
Why most discovered true associations are inflated
John P. A. Ioannidis
EPIDEMIOLOGY (2008)
Selective Reporting of Adjusted Estimates in Observational Epidemiology Studies: Reasons and Implications for Meta-analyses
Jaime Peters et al.
EVALUATION & THE HEALTH PROFESSIONS (2008)
Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation
Bruce G. Haffty et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
The Completeness of Reporting (CORE) index identifies important deficiencies in observational study conference abstracts
Michelle E. Kho et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study
Peter Paschka et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Interactions between treatment and continuous covariates: A step toward individualizing therapy
Patrick Royston et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical Trials
Brian R. Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue
Elena Hartmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Survival end point reporting in randomized cancer clinical trials: A review of major journals
Simone Mathoulin-Pelissier et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Leave 'em alone - Why continuous variables should be analyzed as such
Carl van Walraven et al.
NEUROEPIDEMIOLOGY (2008)
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
Kerry Dwan et al.
PLOS ONE (2008)
The impact of time-dependent bias in proportional hazards modelling
Jan Beyersmann et al.
STATISTICS IN MEDICINE (2008)
2008 Best Practices for Respositories - Collection, storage, retrieval and distribution of biological materials for research
[Anonymous]
CELL PRESERVATION TECHNOLOGY (2008)
Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models
Martin Wolkewitz et al.
CRITICAL CARE (2008)
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
Ashish B. Rajput et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Selection of important variables and determination of functional form for continuous predictors in multivariable model building
Willi Sauerbrei et al.
STATISTICS IN MEDICINE (2007)
Different prognostic value of cytokeratin-19 mRNA-positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer
Michail Ignatiadis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Almost all articles on cancer prognostic markers report statistically significant results
Panayiotis A. Kyzas et al.
EUROPEAN JOURNAL OF CANCER (2007)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
Erik von Elm et al.
PLOS MEDICINE (2007)
Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration
Jan P. Vandenbroucke et al.
PLOS MEDICINE (2007)
Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer
Vanesa Gregorc et al.
CANCER (2007)
Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy
Y. Nieto et al.
BRITISH JOURNAL OF CANCER (2007)
A new proposal for multivariable modelling of time-varying effects in survival data based on fractional polynomial time-transformation
Willi Sauerbrei et al.
BIOMETRICAL JOURNAL (2007)
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system
Clifford A. Hudis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Relaxing the rule of ten events per variable in logistic and Cox regression
Eric Vittinghoff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Quality of reporting of cancer prognostic marker studies: Association with reported prognostic effect
Panayiotis A. Kyzas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Joint estimation of time-dependent and non-linear effects of continuous covariates on survival
Michal Abrahamowicz et al.
STATISTICS IN MEDICINE (2007)
Calcified carotid artery atheroma and stroke - A systematic review
Muralidhar Mupparapu et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2007)
Multiple imputation: current perspectives
Michael G. Kenward et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2007)
A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer
S. Popat et al.
ANNALS OF ONCOLOGY (2006)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Lisa M. McShane et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975
F. Efficace et al.
ANNALS OF ONCOLOGY (2006)
Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: A clinical example
Geert J. M. G. van der Heijden et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Review: A gentle introduction to imputation of missing values
A. Rogier T. Donders et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome
Madhuri Wadehra et al.
CANCER (2006)
End points for adjuvant therapy trials: Has the time come to accept disease-free survival as a surrogate end point for overall survival?
Sharlene Gill et al.
ONCOLOGIST (2006)
Dichotomizing continuous predictors in multiple regression: a bad idea
P Royston et al.
STATISTICS IN MEDICINE (2006)
Evidence-based assessment and application of prognostic markers: The long way from single studies to meta-analysis
Willi Sauerbrei et al.
COMMUNICATIONS IN STATISTICS-THEORY AND METHODS (2006)
Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: Treatment results of intergroup protocol INT-0102
LF Hutchins et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Outcome selection bias in meta-analysis
PR Williamson et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2005)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
EUROPEAN JOURNAL OF CANCER (2005)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
LM McShane et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
LM McShane et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
LM McShane et al.
NATURE CLINICAL PRACTICE UROLOGY (2005)
Selective reporting biases in cancer prognostic factor studies
PA Kyzas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Opinion - Bias as a threat to the validity of cancer molecular-marker research
DF Ransohoff
NATURE REVIEWS CANCER (2005)
Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer
IM Stefansson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Is treatment with interferon-α effective in all patients with metastatic renal carcinoma?: A new approach to the investigation of interactions
P Royston et al.
BRITISH JOURNAL OF CANCER (2004)
Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials
P Royston et al.
STATISTICS IN MEDICINE (2004)
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines
A Burton et al.
BRITISH JOURNAL OF CANCER (2004)
Time-dependent bias was common in survival analyses published in leading clinical journals
C van Walraven et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Neutral endopeptidase protein expression and prognosis in localized prostate cancer
I Osman et al.
CLINICAL CANCER RESEARCH (2004)
Confidence intervals for the effect of a prognostic factor after selection of an 'optimal' cutpoint
N Holländer et al.
STATISTICS IN MEDICINE (2004)
A systematic review of molecular and biological tumor markers in neuroblastoma
RD Riley et al.
CLINICAL CANCER RESEARCH (2004)
A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions
KJ Ottenbacher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Issues in the reporting of epidemiological studies: a survey of recent practice
SJ Pocock et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker
MS Pepe et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Survival analysis part IV: Further concepts and methods in survival analysis
TG Clark et al.
BRITISH JOURNAL OF CANCER (2003)
Survival Analysis Part III: Multivariate data analysis - choosing a model and assessing its adequacy and fit
MJ Bradburn et al.
BRITISH JOURNAL OF CANCER (2003)
Survival Analysis Part II: Multivariate data analysis - an introduction to concepts and methods
MJ Bradburn et al.
BRITISH JOURNAL OF CANCER (2003)
Evaluation of sampling strategies for modeling survival of uveal malignant melanoma
T Kivelä et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Survival analysis part I: Basic concepts and first analyses
TG Clark et al.
BRITISH JOURNAL OF CANCER (2003)
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
B Martin et al.
BRITISH JOURNAL OF CANCER (2003)
Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future
RD Riley et al.
BRITISH JOURNAL OF CANCER (2003)
Current perspectives on HER2 testing:: A review of national testing guidelines
M Bilous et al.
MODERN PATHOLOGY (2003)
Statistics Notes - Interaction revisited: the difference between two estimates
DG Altman et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment
EE Ntzani et al.
LANCET (2003)
Cytoplasmic p21(WAF1/CIP1) expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis
ZE Winters et al.
BREAST CANCER RESEARCH (2003)
Multivariate analysis of prognostic factors in patients with glioblastoma
J Lutterbach et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2003)
DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study
PL Barratt et al.
LANCET (2002)
Prognostic factors in non-small cell lung cancer - A decade of progress
MD Brundage et al.
CHEST (2002)
Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
P Royston et al.
STATISTICS IN MEDICINE (2002)
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls
SJ Pocock et al.
LANCET (2002)
Quantification of the completeness of follow-up
TG Clark et al.
LANCET (2002)
Confessions of a pragmatic statistician
C Chatfield
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN (2002)
Logistic regression in the medical literature: Standards for use and reporting, with particular attention to one medical domain
SC Bagley et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Value of flow diagrams in reports of randomized controlled trials
M Egger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
D Moher et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
DG Altman et al.
ANNALS OF INTERNAL MEDICINE (2001)
Prognostic factor studies in oncology: Osteosarcoma as a clinical example
SM Bentzen
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates
FY Hsieh et al.
CONTROLLED CLINICAL TRIALS (2000)
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma
K Kawakami et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Time-dependent relevance of steroid receptors in breast cancer
D Coradini et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Subgroup analysis and other (mis)uses of baseline data in clinical trials
SF Assmann et al.
LANCET (2000)
Share Paper
